Bayer has added another phase 3 trial into its registration programme for oral Factor XIa inhibitor asundexian, signalling growing confidence in a drug that generated mixed results in phase 2.

Australian-US biotech Opthea Ltd has reported disappointing phase 3 results with its lead drug for vision-robbing disease wet age-related macular degeneration (AMD), throwing its future into doubt.

See what moon phase it is tonight and find out when you can see the rest of the moon phases for 2025. Today, June 5, 2025, the moon is 9 days old and is in the Waxing Gibbous phase of its lunar cycle.

The objective response rate for LM was 51.6%, including a 15.6% complete response, and the disease control rate was 81.3% by BICR in the LM efficacy evaluable ... supporting its effective CNS ...

Holy God, Holy Mighty One, Holy Immortal One, have mercy on us and the whole world. (3 times) Jesus, King of Mercy, we trust in You!

The 2024/25 UEFA Champions League kicked off on 17 September and ran to the final in Munich on 31 May, with the best of the best doing battle once again to be crowned the elite side in Europe ...